PlainBillCongress, translated.Legislation. Context. Public interest.Referred to the House Committee on Energy and Commerce.
Congressional Research Service
No official summary is available in the imported record yet.
People & committees
Rep. Hinson, Ashley [R-IA-2] · R–IA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We also preserved the text version used in the PlainBill explanation below.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 20, 2026. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.10093 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.10093 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.10093 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.10093 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.
PlainBill explanation
Based on the full Introduced in House · 2026-08-13 text. This explanation has not received human editorial review. This overview describes the proposal’s major provisions; it does not establish what its real-world effects would be.
This bill would create a federal trust fund for research into early cancer screening, prevention, treatments, and innovative therapies. It would authorize appropriations equal to 10% of annual gross import duties collected on tobacco and tobacco substitutes. This authorizes future funding; it does not itself appropriate the money.
There is established in the Treasury a trust fund to be known as the Cancer Research Trust Fund
There are authorized to be appropriated to the Fund amounts equal to ten percent of the total amount collected in gross duties per fiscal year on tobacco and tobacco substitute articles imported into the United States.
shall use amounts made available to the Fund to carry out critical research and development into early cancer screening prevention, treatments, and innovative therapies.
The proposed Cancer Research Trust Fund Act would establish the fund in the Treasury, consisting of money appropriated under the bill.
This Act may be cited as the Cancer Research Trust Fund Act.
There is established in the Treasury a trust fund to be known as the Cancer Research Trust Fund (referred to in this section as the Fund) to be consisting of amounts appropriated as provided in this section.
On request, the Treasury Secretary would have to transfer money from the fund to the Health and Human Services Secretary in amounts necessary to carry out the fund's purposes.
On request, the Secretary of the Treasury shall transfer from the Fund to the Secretary of Health and Human Services such amounts necessary to carry out the purposes of the Fund.
The Health and Human Services Secretary would have to use available funding for cancer research and development, coordinating with the official the bill calls the Secretary of War through the Director of the Defense Health Agency.
The Secretary of Health and Human Services (in coordination with the Secretary of War acting through the Director of the Defense Health Agency) shall use amounts made available to the Fund to carry out critical research and development into early cancer screening prevention, treatments, and innovative therapies.
The Health and Human Services Secretary would have to prioritize research addressing rare cancers and cancers affecting children. This establishes research priorities among the program's intended beneficiaries and does not, by itself, establish a materially narrow special benefit under the targeted-benefits definition.
In carrying out the purposes under paragraph (1), the Secretary of Health and Human Services shall prioritize rare cancers and cancers affecting pediatric populations.
The supplied actions snapshot, updated August 20, 2026, records introduction in the House and referral to the House Committee on Energy and Commerce on August 13, 2026.
Source snapshot updated 2026-08-20T13:30:53Z. 2026-08-13: Referred to the House Committee on Energy and Commerce. 2026-08-13: Introduced in House
A closer look
Reviewed version: Introduced in House · 2026-08-13. These findings describe provisions and who may benefit; they are not judgments of waste, corruption, or motive.
This review covers the supplied bill text. “None identified” does not rule out provisions in later versions or accompanying reports and disclosures.
Provisions outside the bill’s main subject, or policy changes attached to appropriations.
None identified in the reviewed text
No unrelated provision or policy rider was identified after reviewing the complete supplied introduced text. This conclusion is limited to that version.
Spending directed to particular recipients or places outside ordinary competitive or formula-based allocation.
None identified in the reviewed text
No congressionally directed spending for a particular recipient or place was identified after reviewing the complete supplied introduced text. This conclusion is limited to that version; formal earmark status cannot be established without the relevant accompanying materials.
Narrow exceptions, exemptions, or preferential treatment that warrant a closer look.
None identified in the reviewed text
No qualifying materially narrow carve-out, special exemption, or preferential treatment was identified after reviewing the complete supplied introduced text. Research priorities among a program's intended beneficiaries do not alone warrant a finding under this category. This conclusion is limited to the supplied version.
Full text preserved for this analysis. Legislative record snapshot: Aug 20, 2026. How PlainBill uses AI